Drug Trial Radar · NCT06742281
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
432
Actual
Start
Dec 5, 2024
Primary completion
Jun 15, 2026
Study completion Jun 15, 2026
Sponsor
- Lead sponsor
- CyanVac LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Biomedical Advanced Research and Development Authority
- First posted
- Dec 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently approved COVID-19 vaccine in the prevention of symptomatic, RT-PCR-confirmed SARS-CoV-2 infection. The trial will enroll up to 434 healthy participants.
Conditions
- COVID-19
Interventions
CVXGA (CVXGA50)Biological
CVXGA is a recombinant parainfluenza virus type 5 (PIV5) engineered to express SARS-CoV-2 S gene from the KP.2 strain.
COMIRNATY®Biological
COMIRNATY® (COVID-19 vaccine, mRNA) suspension for injection, for intramuscular use, 2024-2025 Formula (BioNTech Manufacturing GmbH \[Mainz, Germany\] and Pfizer Inc. \[New York, NY\]) will be used as the comparator vaccine for this study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants with symptomatic COVID-19 after boost with CVXGA (CVXGA50) compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula) to compare differences in relative vaccine efficacy.Time frame: Day 14 to Day 366 post-vaccination.
Locations
55 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
Velocity Clinical Research, Phoenix
Phoenix, Arizona
Velocity Clinical Research, Chula Vista
Chula Vista, California
Velocity Clinical Research, San Diego
La Mesa, California
Imax Clinical Trials
La Palma, California
Artemis Institute for Clinical Research
Riverside, California
Clinical Innovations Inc. dba CITrials
Riverside, California
Avacare
Sacramento, California
Collaborative Neuroscience Research, LLC
Torrance, California
Velocity Clinical Research, Washington DC
Washington D.C., District of Columbia
Velocity Clinical Research, Hallandale Beach
Hallandale, Florida
Homestead Associates in Research, Inc
Homestead, Florida
Biscayne Clinical Research
North Miami Beach, Florida
Headlands Research Orlando
Orlando, Florida
Best Choice Medical and Research Service
Pembroke Pines, Florida
Forcare Clinical Research
Tampa, Florida
Guardian Angel Research Center
Tampa, Florida
Lifeline Primary Care/Avacare
Lilburn, Georgia
Velocity Clinical Research, Savannah
Savannah, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Velocity Clinical Research, Boise
Meridian, Idaho
Velocity Clinical Research, Sioux City
Sioux City, Iowa
Velocity Clinical Research, Covington
Covington, Louisiana
Velocity Clinical Research, Lafayette
Lafayette, Louisiana
Velocity Clinical Research, New Orleans
New Orleans, Louisiana
CBH Health
Gaithersburg, Maryland
Advanced Primary and Geriatric Care/Avacare
Rockville, Maryland
Velocity Clinical Research, Rockville
Rockville, Maryland
DM Clinical Research
Southfield, Michigan
Velocity Clinical Research - Norfolk
Norfolk, Nebraska
Quality Clinical Research, Inc
Omaha, Nebraska
Velocity Clinical Research, Omaha
Omaha, Nebraska
DM Clinical Research
Jersey City, New Jersey
Velocity Clinical Research, Binghamton
Binghamton, New York
Rochester Clinical Research
Rochester, New York
Trial Management Associates, LLC
Wilmington, North Carolina
Velocity Clinical Research, Cleveland
Beachwood, Ohio
Velocity Clinical Research, Mt. Auburn
Cincinnati, Ohio
Velocity Clinical Research, Springdale
Cincinnati, Ohio
Tekton Research, LLC
Yukon, Oklahoma
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.